Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway

Xiaoyang Liu(Ningbo University), Ling Jing(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shuping Yang(Shandong Provincial Hospital), Jiajun Chen(Union Hospital), Liming Li(Fudan University), Hongfei Wang(Second Military Medical University), Shilin Li(Fudan University), Qi Ling(Jilin Medical University), Mingying Xia(Fudan University), Libo Wang(Jilin University)
Molecular Medicine Reports
October 29, 2014
Cited by 37


Related Papers